Transcode Therapeutics, Inc. (RNAZ) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US89357L5012
Transcode Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -27.98 m USD |
| EBIT | -34.51 m USD |
| Net income | -34.66 m USD |
| Diluted EPS – continuing operations | -52.59 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Transcode Therapeutics, Inc.
TransCode Therapeutics, Inc., a clinical-stage company, develops immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers. The company's therapeutic candidate comprises SEVIPROTIMUT-L for the adjuvant treatment of patients with Stages IIB and IIC melanoma that has completed Phase 2 clinical trial; TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cell viability in various cancers comprising breast, pancreatic, ovarian, colon cancer, glioblastomas, and others that has completed Phase 1 clinical trial. Its preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1 and two indication agnostic programs; TTX-RIGA, an RNA- based agonist of the retinoic acid-inducible gene I targeting activation of innate immunity in the tumor microenvironment; and TTX-siMYC, an siRNA-based MYC inhibitor. The company is also developing oncolytic virus therapy. TransCode Therapeutics, Inc. has strategic collaboration agreement with The University of Texas M. D. Anderson Cancer Center. The company was incorporated in 2016 and is based in Boston, Massachusetts.
More stocks
- All In FutureTech Alliance, Inc. (AIFA)
- CREDITRISKMONITOR COM INC (CRMZ)
- CEL SCI CORP (CVM)
- FiEE, Inc. (FIEE)
- MicroAlgo Inc. (MLGO)
- Estrella Immunopharma, Inc. (ESLA)
- Helio Corp /FL/ (HLEO)
- GEX MANAGEMENT, INC. (GXXM)
- CHINA PHARMA HOLDINGS, INC. (CPHI)
- Gouverneur Bancorp, Inc./MD/ (GOVB)
- Caro Holdings Inc. (CAHO)
- BranchOut Food Inc. (BOF)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.